Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer

The fifth International Union Against Cancer tumor node metastasis (UICC TNM) classification, basedon the number of metastatic lymph nodes (LN), has proved to be areliable and objective method for predicting the prognosis of patientswith gastric cancer. However, the prognosis of patients with T3 gas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgery 2002-03, Vol.26 (3), p.323-329
Hauptverfasser: Hyung, Woo Jin, Noh, Sung Hoon, Yoo, Chang Hak, Huh, Ji Hun, Shin, Dong Woo, Lah, Ki Hyeok, Lee, Jun Ho, Choi, Seung Ho, Min, Jin Sik
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 329
container_issue 3
container_start_page 323
container_title World journal of surgery
container_volume 26
creator Hyung, Woo Jin
Noh, Sung Hoon
Yoo, Chang Hak
Huh, Ji Hun
Shin, Dong Woo
Lah, Ki Hyeok
Lee, Jun Ho
Choi, Seung Ho
Min, Jin Sik
description The fifth International Union Against Cancer tumor node metastasis (UICC TNM) classification, basedon the number of metastatic lymph nodes (LN), has proved to be areliable and objective method for predicting the prognosis of patientswith gastric cancer. However, the prognosis of patients with T3 gastriccancer is still heterogeneous. This study was carried out toinvestigate the validity of metastatic LN ratio as a prognostic factorin T3 gastric cancer. A retrospective analysis was performed on a totalof 833 patients that had either T3N1M0 (n = 504) orT3N2M0 (n = 329) gastric cancer by the fifth UICCclassification. A preliminary analysis revealed the cutoff values forT3N1M0 to be 10% and for T3N2M0 to be 25%. The mean metastatic LNratio was 9.0% for T3N1M0 cancer and 26.9% for T3N2M0 cancer. For theT3N1M0 stage, the patients who showed less than 10% of the metastaticLN ratio were grouped as N1‐low with the others grouped as N1‐high. Forthe T3N2M0 stage group, those who had less than 25% of the metastaticLN ratio were grouped as N2‐low, the remainder as N2‐high. Themetastatic LN ratio decreased in proportion to the extent oflymphadenectomy and it increased in relation to the increasing scale ofthe fourth N classification. The rates of recurrence were significantlydifferent according to the metastatic LN ratio in N1 and N2classification of the fifth UICC classification (p < 0.05). The5‐year survival rates after gastrectomy decreased significantly byincreasing the metastatic LN ratio in both T3N1M0 cancers (p =0.0026) and T3N2M0 cancers (p = 0.0057). The metastatic LN ratiowas an independent risk factor for recurrence and poor prognosis. Ourdata suggest that the metastatic LN ratio is a significant prognosticfactor for T3 gastric cancer. Furthermore, the application of themetastatic LN ratio can provide information not only about the extentof LN metastasis but also about the extent of lymphadenectomy in T3gastric cancer.
doi_str_mv 10.1007/s00268-001-0227-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_219941731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>710484401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1749-5786ddaaa18b87dea17eb36da23e0d828da5eec6b82e6f7e40153e6b8cd52cd53</originalsourceid><addsrcrecordid>eNqFUE1PwzAMjRBIjMEP4BZxD-SjTdobaIKNaXyIDXGMssQdnbZmJJ3Q_j0p5c7Bsv2eny0_hC4ZvWaUqptIKZcFoZQRyrki5REasExwwgUXx2hAhcxSzcQpOotxneaUpHKApq_Brxof29rieb1q6qq2prGAfYWfoDWxNR01O2x3n_jZO8BvCfC4bvBCjBMdEjvqFOEcnVRmE-HiLw_R-8P9YjQhs5fx4-huRixTWUlyVUjnjDGsWBbKgWEKlkI6wwVQV_DCmRzAymXBQVYKMspyAam1LucpxBBd9Xt3wX_tIbZ67fehSSc1Z2WZMZXeHCLWD9ngYwxQ6V2otyYcNKO6c0z3junkhO4c02XS3Paa73oDh_8F-mM6n_-CCeugUvwACG1wbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219941731</pqid></control><display><type>article</type><title>Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer</title><source>Access via Wiley Online Library</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hyung, Woo Jin ; Noh, Sung Hoon ; Yoo, Chang Hak ; Huh, Ji Hun ; Shin, Dong Woo ; Lah, Ki Hyeok ; Lee, Jun Ho ; Choi, Seung Ho ; Min, Jin Sik</creator><creatorcontrib>Hyung, Woo Jin ; Noh, Sung Hoon ; Yoo, Chang Hak ; Huh, Ji Hun ; Shin, Dong Woo ; Lah, Ki Hyeok ; Lee, Jun Ho ; Choi, Seung Ho ; Min, Jin Sik</creatorcontrib><description>The fifth International Union Against Cancer tumor node metastasis (UICC TNM) classification, basedon the number of metastatic lymph nodes (LN), has proved to be areliable and objective method for predicting the prognosis of patientswith gastric cancer. However, the prognosis of patients with T3 gastriccancer is still heterogeneous. This study was carried out toinvestigate the validity of metastatic LN ratio as a prognostic factorin T3 gastric cancer. A retrospective analysis was performed on a totalof 833 patients that had either T3N1M0 (n = 504) orT3N2M0 (n = 329) gastric cancer by the fifth UICCclassification. A preliminary analysis revealed the cutoff values forT3N1M0 to be 10% and for T3N2M0 to be 25%. The mean metastatic LNratio was 9.0% for T3N1M0 cancer and 26.9% for T3N2M0 cancer. For theT3N1M0 stage, the patients who showed less than 10% of the metastaticLN ratio were grouped as N1‐low with the others grouped as N1‐high. Forthe T3N2M0 stage group, those who had less than 25% of the metastaticLN ratio were grouped as N2‐low, the remainder as N2‐high. Themetastatic LN ratio decreased in proportion to the extent oflymphadenectomy and it increased in relation to the increasing scale ofthe fourth N classification. The rates of recurrence were significantlydifferent according to the metastatic LN ratio in N1 and N2classification of the fifth UICC classification (p &lt; 0.05). The5‐year survival rates after gastrectomy decreased significantly byincreasing the metastatic LN ratio in both T3N1M0 cancers (p =0.0026) and T3N2M0 cancers (p = 0.0057). The metastatic LN ratiowas an independent risk factor for recurrence and poor prognosis. Ourdata suggest that the metastatic LN ratio is a significant prognosticfactor for T3 gastric cancer. Furthermore, the application of themetastatic LN ratio can provide information not only about the extentof LN metastasis but also about the extent of lymphadenectomy in T3gastric cancer.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-001-0227-9</identifier><language>eng</language><publisher>New York: Springer‐Verlag</publisher><subject>Gastric Cancer ; Lymph Node ; Lymph Node Metastasis ; Poor Prognosis ; Retrospective Analysis</subject><ispartof>World journal of surgery, 2002-03, Vol.26 (3), p.323-329</ispartof><rights>2002 International Society of Surgery</rights><rights>Copyright Springer-Verlag 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1749-5786ddaaa18b87dea17eb36da23e0d828da5eec6b82e6f7e40153e6b8cd52cd53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1007%2Fs00268-001-0227-9$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1007%2Fs00268-001-0227-9$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Hyung, Woo Jin</creatorcontrib><creatorcontrib>Noh, Sung Hoon</creatorcontrib><creatorcontrib>Yoo, Chang Hak</creatorcontrib><creatorcontrib>Huh, Ji Hun</creatorcontrib><creatorcontrib>Shin, Dong Woo</creatorcontrib><creatorcontrib>Lah, Ki Hyeok</creatorcontrib><creatorcontrib>Lee, Jun Ho</creatorcontrib><creatorcontrib>Choi, Seung Ho</creatorcontrib><creatorcontrib>Min, Jin Sik</creatorcontrib><title>Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer</title><title>World journal of surgery</title><description>The fifth International Union Against Cancer tumor node metastasis (UICC TNM) classification, basedon the number of metastatic lymph nodes (LN), has proved to be areliable and objective method for predicting the prognosis of patientswith gastric cancer. However, the prognosis of patients with T3 gastriccancer is still heterogeneous. This study was carried out toinvestigate the validity of metastatic LN ratio as a prognostic factorin T3 gastric cancer. A retrospective analysis was performed on a totalof 833 patients that had either T3N1M0 (n = 504) orT3N2M0 (n = 329) gastric cancer by the fifth UICCclassification. A preliminary analysis revealed the cutoff values forT3N1M0 to be 10% and for T3N2M0 to be 25%. The mean metastatic LNratio was 9.0% for T3N1M0 cancer and 26.9% for T3N2M0 cancer. For theT3N1M0 stage, the patients who showed less than 10% of the metastaticLN ratio were grouped as N1‐low with the others grouped as N1‐high. Forthe T3N2M0 stage group, those who had less than 25% of the metastaticLN ratio were grouped as N2‐low, the remainder as N2‐high. Themetastatic LN ratio decreased in proportion to the extent oflymphadenectomy and it increased in relation to the increasing scale ofthe fourth N classification. The rates of recurrence were significantlydifferent according to the metastatic LN ratio in N1 and N2classification of the fifth UICC classification (p &lt; 0.05). The5‐year survival rates after gastrectomy decreased significantly byincreasing the metastatic LN ratio in both T3N1M0 cancers (p =0.0026) and T3N2M0 cancers (p = 0.0057). The metastatic LN ratiowas an independent risk factor for recurrence and poor prognosis. Ourdata suggest that the metastatic LN ratio is a significant prognosticfactor for T3 gastric cancer. Furthermore, the application of themetastatic LN ratio can provide information not only about the extentof LN metastasis but also about the extent of lymphadenectomy in T3gastric cancer.</description><subject>Gastric Cancer</subject><subject>Lymph Node</subject><subject>Lymph Node Metastasis</subject><subject>Poor Prognosis</subject><subject>Retrospective Analysis</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFUE1PwzAMjRBIjMEP4BZxD-SjTdobaIKNaXyIDXGMssQdnbZmJJ3Q_j0p5c7Bsv2eny0_hC4ZvWaUqptIKZcFoZQRyrki5REasExwwgUXx2hAhcxSzcQpOotxneaUpHKApq_Brxof29rieb1q6qq2prGAfYWfoDWxNR01O2x3n_jZO8BvCfC4bvBCjBMdEjvqFOEcnVRmE-HiLw_R-8P9YjQhs5fx4-huRixTWUlyVUjnjDGsWBbKgWEKlkI6wwVQV_DCmRzAymXBQVYKMspyAam1LucpxBBd9Xt3wX_tIbZ67fehSSc1Z2WZMZXeHCLWD9ngYwxQ6V2otyYcNKO6c0z3junkhO4c02XS3Paa73oDh_8F-mM6n_-CCeugUvwACG1wbw</recordid><startdate>200203</startdate><enddate>200203</enddate><creator>Hyung, Woo Jin</creator><creator>Noh, Sung Hoon</creator><creator>Yoo, Chang Hak</creator><creator>Huh, Ji Hun</creator><creator>Shin, Dong Woo</creator><creator>Lah, Ki Hyeok</creator><creator>Lee, Jun Ho</creator><creator>Choi, Seung Ho</creator><creator>Min, Jin Sik</creator><general>Springer‐Verlag</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200203</creationdate><title>Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer</title><author>Hyung, Woo Jin ; Noh, Sung Hoon ; Yoo, Chang Hak ; Huh, Ji Hun ; Shin, Dong Woo ; Lah, Ki Hyeok ; Lee, Jun Ho ; Choi, Seung Ho ; Min, Jin Sik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1749-5786ddaaa18b87dea17eb36da23e0d828da5eec6b82e6f7e40153e6b8cd52cd53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Gastric Cancer</topic><topic>Lymph Node</topic><topic>Lymph Node Metastasis</topic><topic>Poor Prognosis</topic><topic>Retrospective Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hyung, Woo Jin</creatorcontrib><creatorcontrib>Noh, Sung Hoon</creatorcontrib><creatorcontrib>Yoo, Chang Hak</creatorcontrib><creatorcontrib>Huh, Ji Hun</creatorcontrib><creatorcontrib>Shin, Dong Woo</creatorcontrib><creatorcontrib>Lah, Ki Hyeok</creatorcontrib><creatorcontrib>Lee, Jun Ho</creatorcontrib><creatorcontrib>Choi, Seung Ho</creatorcontrib><creatorcontrib>Min, Jin Sik</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hyung, Woo Jin</au><au>Noh, Sung Hoon</au><au>Yoo, Chang Hak</au><au>Huh, Ji Hun</au><au>Shin, Dong Woo</au><au>Lah, Ki Hyeok</au><au>Lee, Jun Ho</au><au>Choi, Seung Ho</au><au>Min, Jin Sik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer</atitle><jtitle>World journal of surgery</jtitle><date>2002-03</date><risdate>2002</risdate><volume>26</volume><issue>3</issue><spage>323</spage><epage>329</epage><pages>323-329</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><abstract>The fifth International Union Against Cancer tumor node metastasis (UICC TNM) classification, basedon the number of metastatic lymph nodes (LN), has proved to be areliable and objective method for predicting the prognosis of patientswith gastric cancer. However, the prognosis of patients with T3 gastriccancer is still heterogeneous. This study was carried out toinvestigate the validity of metastatic LN ratio as a prognostic factorin T3 gastric cancer. A retrospective analysis was performed on a totalof 833 patients that had either T3N1M0 (n = 504) orT3N2M0 (n = 329) gastric cancer by the fifth UICCclassification. A preliminary analysis revealed the cutoff values forT3N1M0 to be 10% and for T3N2M0 to be 25%. The mean metastatic LNratio was 9.0% for T3N1M0 cancer and 26.9% for T3N2M0 cancer. For theT3N1M0 stage, the patients who showed less than 10% of the metastaticLN ratio were grouped as N1‐low with the others grouped as N1‐high. Forthe T3N2M0 stage group, those who had less than 25% of the metastaticLN ratio were grouped as N2‐low, the remainder as N2‐high. Themetastatic LN ratio decreased in proportion to the extent oflymphadenectomy and it increased in relation to the increasing scale ofthe fourth N classification. The rates of recurrence were significantlydifferent according to the metastatic LN ratio in N1 and N2classification of the fifth UICC classification (p &lt; 0.05). The5‐year survival rates after gastrectomy decreased significantly byincreasing the metastatic LN ratio in both T3N1M0 cancers (p =0.0026) and T3N2M0 cancers (p = 0.0057). The metastatic LN ratiowas an independent risk factor for recurrence and poor prognosis. Ourdata suggest that the metastatic LN ratio is a significant prognosticfactor for T3 gastric cancer. Furthermore, the application of themetastatic LN ratio can provide information not only about the extentof LN metastasis but also about the extent of lymphadenectomy in T3gastric cancer.</abstract><cop>New York</cop><pub>Springer‐Verlag</pub><doi>10.1007/s00268-001-0227-9</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-2313
ispartof World journal of surgery, 2002-03, Vol.26 (3), p.323-329
issn 0364-2313
1432-2323
language eng
recordid cdi_proquest_journals_219941731
source Access via Wiley Online Library; SpringerLink Journals - AutoHoldings
subjects Gastric Cancer
Lymph Node
Lymph Node Metastasis
Poor Prognosis
Retrospective Analysis
title Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A21%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Significance%20of%20Metastatic%20Lymph%20Node%20Ratio%20in%20T3Gastric%20Cancer&rft.jtitle=World%20journal%20of%20surgery&rft.au=Hyung,%20Woo%20Jin&rft.date=2002-03&rft.volume=26&rft.issue=3&rft.spage=323&rft.epage=329&rft.pages=323-329&rft.issn=0364-2313&rft.eissn=1432-2323&rft_id=info:doi/10.1007/s00268-001-0227-9&rft_dat=%3Cproquest_cross%3E710484401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219941731&rft_id=info:pmid/&rfr_iscdi=true